John McGuire, MD
Physical Medicine & Rehabilitation · Milwaukee, WINPI 1003869744
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $47,348 of the $74,690 with a category attached, or 63.4%. AbbVie accounts for 68.0% of it on its own, with 7 other manufacturers making up the rest. Among physical medicine & rehabilitation clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 193 payments — averaging $386.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$51K
- Merz Pharmaceuticals, LLC$12K
- Ipsen Biopharmaceuticals, Inc$7K
- Pacira Pharmaceuticals Incorporated$4K
- Merz North America, Inc.$1K
- Medtronic$460
- plus $149 from 2 others
Across 27 payments — averaging $4532.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ipsen Pharma SAS$92K
- Merz Pharmaceuticals, LLC$31K
What the payments were for
- Consulting fees$14,32019%
- Speaking & faculty fees$47,34863%
- Travel & lodging$4,5666%
- Food & beverage$8,41411%
- Education$430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 88 | $50,776 |
| Merz Pharmaceuticals, LLC | 40 | $11,776 |
| Ipsen Biopharmaceuticals, Inc | 27 | $6,547 |
| Pacira Pharmaceuticals Incorporated | 16 | $3,550 |
| Merz North America, Inc. | 15 | $1,431 |
| Medtronic(2 entities) | 4 | $460 |
| MDD US Operations, LLC | 1 | $119 |
| Pfizer | 2 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$46,904
- XEOMIN$11,965
- DYSPORT$6,026
- Iovera$2,490
- Zilretta$942
- EXPAREL$153
- SYNCHROMEDII$152
- MYOBLOC$119
- SYNCHROMED$115
How this compares
$74,690 in reported general payments places this provider in the 95th percentile of 207 physical medicine & rehabilitation providers in Wisconsin.
See all physical medicine & rehabilitation providers in Wisconsin →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 226 | $6,231 |
| Dantrolene Sodium | 24 | $2,154 |
| Tizanidine Hcl | 61 | $1,625 |
| Gabapentin | 61 | $1,312 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $346 |
| Clonazepam | 15 | $244 |
| Diazepam | 25 | $184 |
| Cyclobenzaprine Hcl | 24 | $133 |
| Tramadol Hcl | 16 | $68 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Milwaukee
- Nicholas KetchumMilwaukee$573K
- Christopher CronsellMilwaukee$353K
- Karin GoodfriendMilwaukee$191K
- Erin McGonigleMilwaukee$66K
- Noelle LiskaMilwaukee$13K
- Trinh TruongMilwaukee$11K
- Bindiya ShahMilwaukee$10K
- Salman AljilaniMilwaukee$4K
- Lori BrooksMilwaukee$4K
- Carla WrightMilwaukee$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.